Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Thomas N. Bulleit ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Senators Ask HHS To Step Up Scrutiny Of Pods Under Sunshine Act
On March 19, 2019, Senators Chuck Grassley (R-IA) and Ron Wyden (D-OR) of the Senate Finance Committee ("SFC") wrote a letter (the "POD Letter") to the HHS Office of Inspector General ("OIG")
United States
3 May 2019
2
Impact Of Value-Based Health Care On The Medical Device Industry: Three Takeaways From The Case For Transformation
In the world of fee-for-service health care, most medical devices were sold to hospitals or other health care providers for use in the diagnosis or treatment of patients.
United States
11 Sep 2017
3
Outlook 2017 Teleconference: Revisiting the Trump Administration's Impact on Life Sciences and Health Care—the First 100 Days
On Tuesday, May 2, Ropes & Gray hosted a teleconference, "Outlook 2017 Teleconference: Revisiting the Trump Administration's Impact on Life Sciences and Health Care – the First 100 Days," on the potential regulatory and compliance impact of the Trump Administration on life sciences and health care companies.
United States
24 May 2017
4
Outlook 2017 for Health Care and Life Sciences—What to Expect from HHS, FDA and Congress (podcast)
What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook?
United States
29 Dec 2016
5
Physician-Owned Distributorships Under Scrutiny At Senate Finance Committee Hearing
On November 17, 2015, the Senate Finance Committee ("SFC") held a hearing on physician-owned distributors of implantable medical devices ("PODs").
United States
24 Dec 2015
Links to Result pages
 
1